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What is already known about the topic?
•• This original study was implemented to address the absence of evidence identified in our prior review. The evidence was 
systematically reviewed and updated on 28 November 2015. The search terms such as ‘tuberculosis’, ‘TB’, ‘palliative’, ‘hospice’, 
‘terminal’ and ‘end-of-life’ were combined within PubMed and MedLine, and no new primary evidence was identified.
•• The new World Health Organization’s (WHO) STOP TB strategy names palliative care as a required component of care, but 
there is no current evidence of the nature or severity of palliative care needs.
•• This WHO strategy includes palliative care in two of its three pillars. However, to date, no data have been generated on 
patient-reported palliative care needs to inform an effective clinical response.
What palliative care–related problems  
do patients with drug-resistant or  
drug-susceptible tuberculosis  
experience on admission to hospital?  
A cross-sectional self-report study
Richard Harding1, Kath Defilippi2,3 and David Cameron4,5
Abstract
Background: The new World Health Organization’s ‘End TB’ strategy specifies palliative care within its strategic pillars. Limited data 
on patient-reported problems are available to inform an effective care response.
Aim: We aimed to (1) identify most burdensome problems, (2) compare intensity of problems for drug-susceptible and drug-resistant 
tuberculosis and (3) identify predictors of problem identifiers.
Design: Cross-sectional self-report quantitative study.
Setting/participants: Self-report palliative care problems (physical, psychological, social and spiritual) were collected among patients 
on admission to a general district hospital with tuberculosis and multidrug-resistant tuberculosis wards in South Africa.
Results: Totally, 114 patients were recruited. The items with worst score responses were worry (60.5%), pain (42.1%), help and advice 
to plan for the future (35.1%), symptoms (29.0%) and ability to share feelings (25.1%). In ordinal logistic regression, age was predictive 
of a higher (worse) score for total Palliative Outcome Scale total score (0.058, 95% confidence interval = 0.0018–0.099, p = 0.005) and 
Factor 2 (interpersonal wellbeing: 0.038, 95% confidence interval = 0.003–0.073, p = 0.031). Interestingly, multidrug-resistant tuberculosis 
was predictive of lower (better) score for both total Palliative Outcome Scale score and Factor 1 (physical and psychological wellbeing). 
Weight, human immunodeficiency virus status and prior treatment were not significantly associated with any of the three.
Conclusion: Currently, patients with drug-susceptible tuberculosis are only admitted to hospital with complications, explaining their 
worse scores. The high burden of physical and psychosocial problems experienced by our sample provides strong evidence of the 
need for palliative care alongside potentially curative options.
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What this paper adds?
•• This study addresses the global health challenge of tuberculosis (TB). Given the dropout from treatment, the difficulties in 
managing drug-resistant TB and TB-related mortality, a recent evidence-based declaration and policy have called for improved 
access to palliative and end-of-life care.
•• It identifies the self-report problems of drug-resistant and drug-susceptible TB patients, and importantly shows that those 
admitted have a high burden of multidimensional problems.
•• Due to policy of forced admission of drug-resistant patients, they have a lower burden of problems than those with drug-
susceptible TB.
Implications for practice, theory or policy
•• The data reveal a high burden of worry, pain, need for help and advice to plan for the future, symptoms, and sharing feelings, 
each of which were scored as being highly burdensome by at least 25% of the sample.
•• Inpatient settings require training and skills to assess and manage multidimensional patient problems alongside attempts to 
treat the disease.
Introduction
In 2013, there were 9 million new tuberculosis (TB) cases, 
and 1.5 million deaths.1 In total, 3.5% of new TB cases and 
20.5% of previously treated cases have multidrug-resistant 
tuberculosis (MDR-TB), that is, resistance to at least iso-
niazid and rifampicin (the two most powerful anti-TB 
drugs).1 In 2013, the World Health Organization (WHO) 
estimates that 480,000 people developed MDR-TB; 9% of 
these had extensive drug-resistant tuberculosis (XDR-TB 
which is defined as MDR-TB plus resistance to at least one 
fluoroquinolone and a second-line injectable). XDR-TB 
patients have lower successful treatment rates than 
MDR-TB.2 MDR-TB has a treatment success rate of 48%, 
22% not completing treatment and a 35% mortality rate.1 
South Africa has the highest TB incidence and prevalence, 
second highest number of diagnosed MDR-TB cases and 
the largest number of HIV-associated TB cases.3
Palliative care is needed for those who may die from their 
TB infection,4,5 especially XDR-TB.6 The new WHO End 
TB strategy calls for palliative care to achieve zero suffer-
ing,7 advocating ‘access to palliative and end-of-life care’.8 
We aimed to measure palliative care-related problems among 
patients with both drug-susceptible and drug-resistant TB on 
admission to hospital. The objectives were as follows: (1) 
measure intensity of physical, psychological social and spir-
itual problems; (2) compare intensity by drug susceptibility 
and (3) determine predictors of problem intensity.
Methods
Design
Cross-sectional self-report.
Setting
TB ward and the MDR-TB ward of a rural South African 
District Hospital, a decentralised TB and MDR-TB 
Treatment Centre. This setting enabled us to us to (1) 
determine the care needs of patients within institutions;9 at 
the time of this study, people in South Africa with MDR-TB 
had treatment initiated in hospital6 and those with drug-
susceptible TB admitted when serious complications arise; 
(2) meet our goal of data implementation for improved 
patient care and outcomes in a defined place of care; a 
novel hospital-based palliative care service in South Africa 
achieved lower admission rates, lower length of stay and 
higher home-death rates;10 and (3) South Africa has one of 
the highest rates of TB/MDR-TB globally, and public hos-
pitals urgently require evidence to manage admissions.
Inclusion/exclusion criteria
Inclusion criteria are as follows: aged 18 years and older, 
confirmed diagnosis of TB, admitted to the hospital during 
preceding week and could voluntarily give informed con-
sent. Exclusion criteria are as follows: professional nurse 
identified patient as not being cognitively able/too ill to 
respond to the study questions (using clinical judgement).
Data collection
Consecutive patients were approached. The African 
Palliative Care Association African Palliative Outcome Scale 
(APCA POS) is a brief multidimensional outcome measure 
of patient problems,11 has sound psychometric properties,12 
is well reported across conditions and settings13–20 and has a 
stable factor structure.18 Answers are scored using Likert 
scales 0–5, and patients may respond verbally or using a 
hand scoring system.21 In order to standardise data collection 
methods among a population with varying levels of literacy, 
a researcher read the questions aloud in isiZulu or English 
and recorded responses. Self-report items are as follows: age, 
gender, has partner/spouse and number of children being 
cared for. The following data were extracted from file: 
weight, history of previous TB diagnoses, response to TB 
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treatment, HIV status and whether patient was currently on 
antiretroviral (ART) treatment. We attempted to extract CD4 
count, but as with previous research22 we found a large 
amount of missing data (49.1%).
Sample size
The sample size of 114 was based on routine data on TB 
admissions and enabled measurement of prevalence for 
any single POS item with a 50% response distribution, and 
for comparison between TB and MDR-TB participants 
(using prior data of African POS data on the physical and 
psychological symptom factor, to detect a difference of 2.5 
between MDR and XDR groups with a standard deviation 
of 4.13, 90% power and 5% significance, n = 114)17 This 
also meets the minimum recommended ratio of 10 
cases:variable23 for the planned analysis.
Analysis
POS items were reversed as necessary, 0 = best and 
5 = worst score. For Objective 1, descriptive analysis was 
undertaken for patient characteristics and APCA POS item 
and factor scores, reporting medians and interquartile 
ranges (IQRs). Response rate and completeness of data 
were also calculated. For Objectives 2 and 3, associations 
with APCA POS factors were identified using ordinal 
logistic regression. Three models were constructed, each 
with the dependent variable of an APCA POS factor (rather 
than using a total score, which could potentially mask vari-
ations between domains). First, univariable analyses were 
conducted with POS factor scores entered as tertiles. As 
ordinal logistic regression provides a cumulative odds 
ratio, the independent variables’ relationship to the depend-
ent variable were first explored in contingency tables to 
determine a uni-directional association with ordinal/con-
tinuous independent variables, then entered as follows: age 
(continuous covariate), gender (factor, two levels of male/
female), drug resistance (factor, two levels of drug resist-
ant/drug susceptible), weight (continuous covariate), HIV 
status (factor, two levels of positive/negative), whether 
patient has a partner (factor, two levels of yes/no), whether 
patient has children (factor, two levels of yes/no) and prior 
TB treatment (factor, two levels of yes/no). ART current 
use was not entered due to collinearity with HIV status 
(84.5% of HIV + patients were on ART). Following each 
univariate analysis, multivariable models were constructed 
(independent variables entered into the multivariable 
model if significant at the 25% level).24 Model fit was 
evaluated using likelihood ratio χ2 test, estimate (log odds 
regression coefficient) and 95% confidence interval, 
Nagelkerke pseudo-r2 as a measure of variance and score 
test of parallel lines to determine assumption of propor-
tional odds held. Cases with missing data were excluded. 
Ethical approval was granted by University of Cape 
Town’s Faculty of Health Sciences Human Research 
Ethics Committee (220/2012) and provincial KwaZulu-
Natal Research Committee (HRKM69/12).
Results
Sample characteristics
In all, 46 patients were excluded, n = 136 were invited to 
participate (response rate: 83.8%), the planned sample of 
n = 114 consented (see Table 1).
Patient problems
The problems with worst median scores were worry, pain 
and other symptoms (see Table 2). In terms of clinical 
importance, items with worst score responses (i.e. at least 
a quarter of the sample scored 4 or 5 in the possible range 
of 0–5) were worry (60.5%), pain (42.1%), help and advice 
(35.1%), symptoms (29.0%) and sharing feelings (25.1%).
Following univariate analysis (Table 3), in multivari-
able models (Table 4), age was predictive of a higher 
(worse) score for total POS score and Factor 2 (interper-
sonal wellbeing). Interestingly, a diagnosis of drug-
resistant TB was predictive of lower (better) score for 
Table 1. Sample characteristics (n = 114).
Full sample, n = 114 TB, n = 55 (48.3%) MDR, n = 59 (51.7%)
Mean age, years (SD) 33.2 (10.4) 33.3 (10.8) 33.1 (10.2)
Female gender n = 76 (66.7%) 40 (74.1) 36 (61)
Partner or not Yes: n = 61 (53.5%) 24 (46.2) 37 (64.9)
Mean weight (SD)
Missing (n = 10a)
51.7 kg (11.1%) 50.4 (10.3) 52.7 (11.7)
Prior TB treatment Yes: n = 64 (56.1%) 25 (46.3) 39 (66.1)
HIV status Positive, n = 97 (85.1%) 48 (87.3) 49 (81.3)
Currently on ART Currently on ART, n = 82 
(84.5% of HIV + participants)
36 (65.5) 46 (78.0)
SD: standard deviation; TB: tuberculosis; MDR: multidrug-resistant; ART: antiretroviral.
aThe 10 participants with missing weight data were unable to stand on the scale.
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both total POS score and Factor 1 (physical and psycho-
logical wellbeing). In contrast, weight, HIV status and 
prior treatment were not significantly associated with 
any outcome.
Discussion
This study is the first to report palliative care–related 
problems of TB patients. The most burdensome prob-
lems were worry, pain and symptoms. Help and advice 
to plan and ability to share feelings were scored in 
the worst response categories by 31% and 22%, 
respectively. The significant physical and psychological 
problems experienced by patients with both TB and 
MDR-TB confirm the need for person-centred, holistic 
palliative care currently proposed for MDR-TB.4,5 The 
worst score related to ‘worry’, requiring assessment and 
management of psychological wellbeing. In all, 79.8% 
had childcare responsibility. These children become 
extremely vulnerable when orphaned, and traditional 
African models of surrogacy may no longer be feasi-
ble.25 Psychosocial support is also important for man-
agement of adverse events related to TB treatment,26,27 
and education, counselling and encouragement support 
Table 2. Baseline APCA African POS scores for full sample of patients with drug responsive and drug-resistant TB, reporting 
previous 3 days (n = 114).
0 (best status) 1 2 3 4 5 (worst status) Median (IQR)
 n (%) n (%) n (%) n (%) n (%) n (%)  
Pain 11 (9.6) 14 (12.3) 20 (17.5) 21 (18.4) 20 (17.5) 28 (24.6) 3.0 (2–4.25)
Symptoms (missing n = 2) 7 (6.1) 7 (6.1) 14 (12.3) 51 (44.7) 23 (20.2) 10 (8.8) 3.0 (2.25–4.0)
Worry 7 (6.1) 5 (4.4) 9 (7.9) 24 (21.1) 33 (28.9) 36 (31.6) 4.0 (3–5)
Life worthwhile 32 (28.1) 33 (28.9) 22 (19.3) 7 (6.1) 3 (2.6) 17 (14.9) 1.0 (0–2)
Share feelings 12 (10.5) 22 (19.3) 29 (25.4) 11 (9.6) 15 (3.2) 25 (21.9) 2.0 (1–4)
At peace 10 (8.8) 30 (26.3) 57 (50.0) 12 (10.5) 4 (3.5) 1 (0.9) 2.0 (1–2)
Help/advice (missing n = 3) 24 (21.1) 24 (21.1) 19 (16.7) 4 (3.5) 5 (4.4) 35 (30.7) 2.0 (1–5)
APCA: The African Palliative Care Association; POS: Palliative Outcome Scale; TB: tuberculosis; IQR: interquartile range.
Table 3. Univariate association with the POS total score, and POS factors as dependent variables.
Independent 
variables
 
 
Outcomes (dependent)
POS total Factor 1: physical and 
psychological
Factor 2: interpersonal 
wellbeing
Factor 3: existential and 
spiritual
B (95% CI)
p
B (95% CI)
p
B (95% CI)
p
B (95% CI)
p
Age 0.060 (0.006 to 2.462)
0.001*
0.025 (−0.008 to 0.059)
0.139*
0.039 (0.005–0.073)
0.024*
0.018 (−0.015 to 0.051)
0.292
Gender (ref: male) 0.291 (−0.453 to 1.036)
0.443
0.349 (−0.393 to 1.091)
0.357
−0.518 (−1.252 to 0.215)
0.166**
<0.001 (−0.722 to 0.722)
1.0
Drug resistance 
(ref: drug 
susceptible)
−0.601 (−1.301 to 0.099)
0.092*
−0.716 (−1.409 to −0.023)
0.043*
0.365 (−0.325 to 1.055)
0.300
−0.278 (−0.954 to 0.399)
0.421
Partner or not (ref: 
yes)
0.394 (−0.322 to 1.109)
0.281
0.223 (−0.479 to 0.925)
0.533
−0.034 (−0.742 to 0.675)
0.926
0.295 (−0.402 to 0.991)
0.407
Have children (ref: 
yes)
−0.873 (−1.780 to 0.034)
0.059*
0.145 (−0.729 to 1.019)
0.745
−0.373 (−1.262 to 0.516)
0.411
−0.369 (−1.246 to 0.508)
0.410
Prior treatment 
(ref: yes)
0.206 (−0.494 to 0.905)
0.564
0.060 (−0.630 to 0.749)
0.865
−0.533 (−1.257 to 0.151)
0.123*
0.416 (−0.272 to 1.103)
0.236*
Weight (kg) 0.014 (−0.019 to 0.047)
0.403
0.029 (−0.004 to 0.063)
0.085*
−0.007 (−0.040 to 0.026)
0.686
−0.007 (−0.039 to 0.025)
0.654
HIV status (ref: yes) −0.360 (−1.318 to 0.599)
0.462
0.139 (−0.810 to 1.088)
0.774
−0.228 (−1.187 to 0.732)
0.642
0.169 (−0.779 to 1.117)
0.726
POS: Palliative Outcome Scale; CI: confidence interval.
*Significant at the 25% level and subsequently entered into the multivariable model.
 at Kings College London - ISS on September 22, 2016pmj.sagepub.comDownloaded from 
866 Palliative Medicine 30(9)
treatment adherence.27 Optimal psychosocial care for 
those with HIV disease continues to be a priority along-
side prevention and treatment;28 the provision of TB 
medical care focused solely on the technical elements of 
treatment would be suboptimal.29–31
Admitted patients with drug-susceptible TB had 
more severe pain, symptoms and worry than those with 
drug-resistant TB. Therefore, those admitted with antic-
ipated positive treatment outcomes also require access 
to palliation. A community-based assessment of pallia-
tive care-related problems experienced by people with 
drug-susceptible TB is required to ensure problems are 
assessed and managed prior to admission, and to ensure 
continuity for those discharged. Existing community 
palliative care teams and hospices are well placed to 
provide education, training and clinical support to hos-
pital teams.6 Training should include treatment side 
effects and effective communication while implement-
ing infection control measures.26 Palliative care and 
infection control for TB patients in hospital and com-
munity have both been successfully provided in South 
Africa.26,32
There are a number of limitations to our data: (1) 
sampling bias through exclusion of those too ill partici-
pate may have led to underestimation of problems; (2) 
exclusion of children due to lack of a validated measure 
although this is in final stages of validation;33 (3) no data 
on potentially confounding variables of functional per-
formance or time since admission/treatment; (4) inter-
views were within 7 days of admission and improvement 
may have already taken place although prior study sug-
gests a slower response to these complex problems;34 (5) 
relative contribution of comorbidities is not known 
although palliative care should be delivered according to 
needs, not diagnosis.
The suffering experienced by TB patients should be 
relieved26,35 This study responds to requests for evi-
dence of palliative care problems.4,5 Prior evidence of 
effectiveness of HIV palliative care (for whom TB is 
common) demonstrated significant improvements for 
the problems reported by our sample.29 Recent trial evi-
dence also found effectiveness for quality of life, psy-
chiatric morbidity and psychosocial problems among 
HIV patients on treatment.28 Therefore, effectiveness of 
palliative care for TB patients is plausible. Our novel 
data should inform care delivery to support the guide-
lines for providing palliative care to patients with TB26 
and the specification of palliative care within the WHO 
TB Strategy.
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